SCHEMBL364907

SCHEMBL364907

O=C(O)c1cc(F)c(OCc2cnc(Cl)c(Cl)c2)cc1F

nearest known ligand 0.53

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 12/20 0.53
▸ KEAP1 Q14145 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ SCN9A Q15858 4/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ RXRA P19793 2/20 0.39
▸ RXRB P28702 2/20 0.39
▸ RXRG P48443 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10236848 0.83 P2RX3 (0.40) MRGPRX4SCN9ATDP1
SCHEMBL367436 0.82 SCN9A (0.46) MRGPRX4SCN9A
SCHEMBL15968165 0.77 FOLH1 (0.55) MRGPRX4RXRARXRBRXRG
SCHEMBL15543236 0.75 SCN9A (0.67) MRGPRX4SCN9A
SCHEMBL30261516 0.74 MRGPRX4 (0.60) MRGPRX4SCN9ARXRARXRB
SCHEMBL25298462 0.72 FOLH1 (0.55) MRGPRX4RXRARXRBRXRG
SCHEMBL30442197 0.72 FOLH1 (0.55) MRGPRX4RXRARXRBRXRG
SCHEMBL4464916 0.70 FOLH1 (0.56) MRGPRX4RXRARXRBRXRG
SCHEMBL22481077 0.69 MRGPRX4 (1.00) MRGPRX4TDP1
SCHEMBL364456 0.69 SCN9A (0.55) MRGPRX4SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2791108-B1 SULFONAMIDE DERIVATIVES PFIZER LTD (GB) 2016-07-27 — — EP disclosed
EP-2791108-B1 SULFONAMIDE DERIVATIVES PFIZER LTD (GB) 2016-07-27 — — EP disclosed
US-9102621-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-11 — — US disclosed
US-9102621-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-11 — — US disclosed
US-9102621-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-11 — — US disclosed
US-9085517-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2015-07-21 — — US disclosed
US-9085517-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2015-07-21 — — US disclosed
US-9085517-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2015-07-21 — — US disclosed
EP-2593431-B1 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS PFIZER LTD (GB) 2014-11-19 — — EP disclosed
EP-2593431-B1 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS PFIZER LTD (GB) 2014-11-19 — — EP disclosed
US-20140315879-A1 Sulfonamide Derivatives PFIZER LIMITED (GB) 2014-10-23 — — US disclosed
US-20140315879-A1 Sulfonamide Derivatives PFIZER LIMITED (GB) 2014-10-23 — — US disclosed
EP-2791108-A1 SULFONAMIDE DERIVATIVES Pfizer Limited (GB) 2014-10-22 — — EP disclosed
WO-2013088315-A1 SULFONAMIDE DERIVATIVES PFIZER LIMITED (GB) 2013-06-20 — — WO disclosed
EP-2593431-A2 CHEMICAL COMPOUNDS Pfizer Limited (GB) 2013-05-22 — — EP disclosed
US-20130109708-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 — — US disclosed
US-20130109708-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 — — US disclosed
US-20130109708-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 — — US disclosed
WO-2012007869-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 — — WO disclosed
WO-2012007869-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109708-A1 Chemical Compounds SCN1A, SCN1B, SCN7A MRGPRX4 761/4885KEAP1 1549/4885NFE2L2 2744/4885
US-20140315879-A1 Sulfonamide Derivatives SCN7A, SCN1B, SCN1A MRGPRX4 312/4885KEAP1 3370/4885NFE2L2 3917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback